StoneX Group’s Park Ha Biological Technology Co BYAH Stock Holding History

StoneX Group’s Portfolio BYAH Stock Details BYAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40	Closed	-$2.54K	–	1263
2025 Q4	$2.54K	Buy	+40	New	+$4.85K	﹤0.01%	1065

Other funds holding BYAH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

StoneX Group's BYAH Position: Q1 2026 in Review

StoneX Group sold out of Park Ha Biological Technology Co (BYAH) in Q1 2026, closing a stake of 40 shares — an estimated $2.54K sold.

StoneX Group first reported a position in BYAH in Q4 2025 and held it in 1 quarter. The position peaked at $2.54K in Q4 2025. 2 funds tracked by Wall St. Rank hold BYAH as of Q1 2026.

StoneX Group reported no remaining Park Ha Biological Technology Co position as of Q1 2026 after selling out during the quarter.
StoneX Group sold 40 Park Ha Biological Technology Co shares in Q1 2026, an estimated $2.54K.
StoneX Group first reported a position in Park Ha Biological Technology Co in Q4 2025 and held it in 1 quarter.
StoneX Group's Park Ha Biological Technology Co position peaked at $2.54K in Q4 2025.
2 funds tracked by Wall St. Rank held Park Ha Biological Technology Co as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.